Niagen Bioscience

Niagen Bioscience, formerly called ChromaDex, sells nicotinamide riboside supplements and reference standards for the natural products industry. Its main product is Tru Niagen, a supplement it acquired along with HealthSpan Research in 2017. The company sells to consumers and to labs and manufacturers that use its reference standards. It is based in Los Angeles, United States.

Frank Jaksch founded the company in 1999 as ChromaDex. It is a public company, traded on NASDAQ under the ticker NAGE. In March 2025, ChromaDex changed its name to Niagen Bioscience. The company has supported over 35 human clinical studies on Niagen's safety and effects. The rename shows how far the company has shifted, from a standards supplier to a consumer supplement brand built on its own clinical research.

Currently, there's a total of 6 job openings at Niagen Bioscience. Over the last 30 days, 3 jobs were added and 1 was removed (job postings usually stay up ~50 days before being removed).¹